000 01700 a2200481 4500
005 20250515001600.0
264 0 _c20051125
008 200511s 0 0 eng d
022 _a0008-5472
024 7 _a10.1158/0008-5472.CAN-04-4402
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aDufès, Christine
245 0 0 _aSynthetic anticancer gene medicine exploits intrinsic antitumor activity of cationic vector to cure established tumors.
_h[electronic resource]
260 _bCancer research
_cSep 2005
300 _a8079-84 p.
_bdigital
500 _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't
650 0 4 _aAdenocarcinoma
_xgenetics
650 0 4 _aAnimals
650 0 4 _aCarcinoma, Squamous Cell
_xgenetics
650 0 4 _aCell Line, Tumor
650 0 4 _aColorectal Neoplasms
_xgenetics
650 0 4 _aFemale
650 0 4 _aGenetic Therapy
_xmethods
650 0 4 _aGenetic Vectors
_xchemistry
650 0 4 _aHumans
650 0 4 _aLac Operon
650 0 4 _aNanostructures
_xchemistry
650 0 4 _aNeoplasms
_xgenetics
650 0 4 _aPlasmids
_xgenetics
650 0 4 _aPolypropylenes
_xchemistry
650 0 4 _aPromoter Regions, Genetic
650 0 4 _aTransfection
_xmethods
650 0 4 _aTumor Necrosis Factor-alpha
_xgenetics
650 0 4 _aUterine Cervical Neoplasms
_xgenetics
650 0 4 _aXenograft Model Antitumor Assays
700 1 _aKeith, W Nicol
700 1 _aBilsland, Alan
700 1 _aProutski, Irina
700 1 _aUchegbu, Ijeoma F
700 1 _aSchätzlein, Andreas G
773 0 _tCancer research
_gvol. 65
_gno. 18
_gp. 8079-84
856 4 0 _uhttps://doi.org/10.1158/0008-5472.CAN-04-4402
_zAvailable from publisher's website
999 _c15798761
_d15798761